Hyperbranched Poly(beta-amino ester) siRNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene delivery systems for siRNA, particularly those based on cationic polymers, face challenges such as non-biodegradability, limited cytotoxicity, and reduced efficiency for siRNA delivery due to the smaller size and higher rigidity of siRNA compared to plasmid DNA.
Innovation Solution
Development of hyperbranched poly(β-amino esters) (pBAEs) with optimized monomer composition and branching density to enhance siRNA complexation, reduce cytotoxicity, and improve gene silencing efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cationic polymers are used for siRNA delivery, then transfection efficiency is improved, but cytotoxicity increases
Solution Approach 1:
The patent changes the chemical parameters of the polymer by introducing biodegradable ester bonds and adjusting the monomer composition (comparing PEI to pBAE derivatives). This modifies the polymer's degradation properties and reduces cytotoxicity while maintaining transfection efficiency through optimized amine content and branching structure.
Solution Approach 2:
The patent creates composite polymer structures by combining different monomer units (amines, diacrylates, and branching agents) to form hyperbranched poly(β-amino esters). This composite approach allows simultaneous optimization of siRNA complexation, cellular uptake, and biodegradability, resolving the contradiction between efficiency and safety.
2Stability of the object's composition
If non-biodegradable polymers are used for gene delivery, then stability is improved, but safety and biocompatibility worsen
Solution Approach 1:
The patent utilizes the phase transition concept in polymer degradation by designing esters that remain stable under physiological conditions (maintaining gene complex integrity) but undergo hydrolysis in specific cellular environments (lysosomes with lower pH), enabling controlled breakdown into non-toxic products that are excreted by the body.
3Device complexity
If linear pBAE structures are used, then simplicity of structure is maintained, but transfection efficiency is limited
Solution Approach 1:
The patent applies segmentation by dividing the polymer structure into multiple functional segments: core amine units for charge, diacrylate linkers for connectivity, and branching points for three-dimensional architecture. This segmented hyperbranched structure increases the number of cationic charge centers and improves siRNA complexation capacity while maintaining synthetic feasibility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hyperbranched pBAEs demonstrate improved siRNA complexation, low cytotoxicity, and high gene silencing efficiency, making them effective for RNA interference (RNAi) mediated gene silencing therapy.
Implementation Method 1
can spontaneously condense negatively charged RNA into complexes with sizes of around 50-200 nm and positive surface charge
Implementation Method 2
these esters can be degraded by ubiquitous esterases present in the body into non-toxic products that can be easily excreted
Data Source
AI summary
Provided herein are hyperbranched poly(β-amino esters) polymers that serve as effective transfection carriers of small interfering RNA (siRNA) for RNA interference (RNAi) mediated gene silencing therapy. These disclosed polymers exhibit outstanding gene silencing efficiency in both easy-to-transfect and hard-to-transfect cells. Furthermore, they are biodegradable and non-toxic.